Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers.

"Authors' Disclosures C. Labbé reports personal fees from Amgen, AstraZeneca, Bristol-Myers Squibb, Jazz Pharmaceuticals, LEO Pharma, Merck, Pfizer, Roche, and Sanofi Genzyme outside the submitted work. P. Desmeules reports grants from AstraZeneca, Pfizer, Roche, Eli-Lilly, EMD Serrono, Novartis, and Amgen outside the submitted work. No disclosures were reported by the other authors."

"This work was supported by the Fondation de l'Institut universitaire de cardiologie et de pneumologie de Québec (FIUCPQ) to Y. Bossé and P. Joubert owing to a generous donation from Mr. Normand Lord, President & CEO, St-Augustin Canada Electric. L-J. Ruel is the recipient of a master's degree scholarship from the Fonds de recherche Québec - Santé (FRQS). P. Joubert is the recipient of a Junior 1 Clinical Research Scholar award from the Fonds de recherche Québec - Santé (FRQS). Y. Bossé holds a Canada Research Chair in Genomics of Heart and Lung Diseases."